Altimmune, Inc.
US ˙ NasdaqGM ˙ US02155H2004

SecurityALT / Altimmune, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership6,133,427 shares
Ownership 7.60%
BlackRock, Inc. ownership in ALT / Altimmune, Inc.

2025-07-16 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,133,427 shares of Altimmune, Inc. (US:ALT). This represents 7.6 percent ownership of the company. In their previous filing dated 2025-02-05 , BlackRock, Inc. had reported owning 6,159,305 shares, indicating a decrease of -0.42 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2025-07-16 2025-07-16 13G/A 6,159,305 6,133,427 -0.42 7.60 -12.64
2025-02-05 2025-02-05 13G/A 4,044,707 6,159,305 52.28 8.70 16.00
2024-01-26 2024-01-26 13G 962,184 4,044,707 320.37 7.50 240.91
2022-07-08 2022-07-08 13G 2,956,267 962,184 -67.45 2.20 -70.27
2022-02-04 2022-02-04 13G 2,956,267 7.40

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ALTIMMUNE COM NEW 02155H200 12,795,277 3,090,979 31.85 39,409 12.49 0.0007
2026-02-12 2025-12-31 13F ALTIMMUNE COM NEW 02155H200 9,704,298 3,331,039 52.27 35,033 45.80 0.0006
2025-11-12 2025-09-30 13F ALTIMMUNE COM NEW 02155H200 6,373,259 699 0.01 24,027 -2.57 0.0004
2025-08-12 2025-06-30 13F ALTIMMUNE COM NEW 02155H200 6,372,560 237,330 3.87 24,662 -19.61 0.0005
2025-05-02 2025-03-31 13F ALTIMMUNE COM NEW 02155H200 6,135,230 -24,075 -0.39 30,676 -30.92 0.0006
2025-02-07 2024-12-31 13F ALTIMMUNE COM NEW 02155H200 6,159,305 693,211 12.68 44,409 32.32 0.0009
2024-11-13 2024-09-30 13F ALTIMMUNE COM NEW 02155H200 5,466,094 145,005 2.73 33,562 -5.15 0.0007
2024-08-13 2024-06-30 13F ALTIMMUNE COM NEW 02155H200 5,321,089 1,278,863 31.64 35,385 -14.01 0.0008
2024-05-10 2024-03-31 13F ALTIMMUNE COM NEW 02155H200 4,042,226 -2,481 -0.06 41,150 -9.57 0.0010
2024-02-13 2023-12-31 13F ALTIMMUNE COM NEW 02155H200 4,044,707 257,791 6.81 45,503 362.18 0.0012
2023-11-13 2023-09-30 13F ALTIMMUNE COM NEW 02155H200 3,786,916 122,642 3.35 9,846 -23.88 0.0003
2023-08-11 2023-06-30 13F ALTIMMUNE COM NEW 02155H200 3,664,274 2,270,219 162.85 12,935 119.89 0.0004
2023-05-12 2023-03-31 13F ALTIMMUNE COM NEW 02155H200 1,394,055 40,022 2.96 5,883 -73.59 0.0002
2023-02-13 2022-12-31 13F ALTIMMUNE COM NEW 02155H200 1,354,033 134,733 11.05 22,274 43.04 0.0007
2022-11-14 2022-09-30 13F ALTIMMUNE COM NEW 02155H200 1,219,300 257,116 26.72 15,571 38.32 0.0005
2022-08-12 2022-06-30 13F ALTIMMUNE COM NEW 02155H200 962,184 -1,974,140 -67.23 11,257 -37.05 0.0004
2022-05-12 2022-03-31 13F ALTIMMUNE COM NEW 02155H200 2,936,324 -19,943 -0.67 17,882 -33.96 0.0005
2022-02-10 2021-12-31 13F ALTIMMUNE COM NEW 02155H200 2,956,267 14,477 0.49 27,079 -18.61 0.0007
2021-11-09 2021-09-30 13F ALTIMMUNE COM NEW 02155H200 2,941,790 384,548 15.04 33,272 32.09 0.0009
2021-08-11 2021-06-30 13F ALTIMMUNE COM NEW 02155H200 2,557,242 1,499,055 141.66 25,188 68.46 0.0007
2021-05-07 2021-03-31 13F ALTIMMUNE COM NEW 02155H200 1,058,187 65,511 6.60 14,952 33.52 0.0004
2021-02-05 2020-12-31 13F ALTIMMUNE COM NEW 02155H200 992,676 495,943 99.84 11,198 70.78 0.0004
2020-11-06 2020-09-30 13F ALTIMMUNE COM NEW 02155H200 496,733 -84,547 -14.54 6,557 5.35 0.0002
2020-08-14 2020-06-30 13F ALTIMMUNE COM NEW 02155H200 581,280 545,063 1,504.99 6,224 5,265.52 0.0002
2020-05-01 2020-03-31 13F ALTIMMUNE COM NEW 02155H200 36,217 2,025 5.92 116 81.25 0.0000
2020-02-13 2019-12-31 13F ALTIMMUNE COM NEW 02155H200 34,192 -354 -1.02 64 -4.48 0.0000
2019-11-08 2019-09-30 13F ALTIMMUNE COM NEW 02155H200 34,546 -1,949 -5.34 67 -22.99 0.0000
2019-08-22 2019-06-30 13F/A-1 ALTIMMUNE COM NEW 02155H200 36,495 36,308 19,416.04 87 0.0000
2019-08-13 2019-06-30 13F ALTIMMUNE COM NEW 02155H200 36,495 36,308 87
2019-05-09 2019-03-31 13F ALTIMMUNE COM NEW 02155H200 187 1 0.54 0 0.0000
2019-02-08 2018-12-31 13F ALTIMMUNE COM NEW 02155H200 186 3 1.64 0 -100.00
2018-11-09 2018-09-30 13F ALTIMMUNE COM NEW 02155H200 183 -2,763,805 -99.99 1 -99.96 0.0000
2017-05-12 2017-03-31 13F PHARMATHENE COM 71714G102 2,763,988 2,760,561 80,553.28 2,243 20,290.91 0.0001
2017-02-10 2016-12-31 13F PHARMATHENE COM 71714G102 3,427 0 0.00 11 10.00 0.0000
2016-11-08 2016-09-30 13F PHARMATHENE COM 71714G102 3,427 1,288 60.22 10 100.00 0.0000
2016-08-10 2016-06-30 13F PHARMATHENE COM 71714G102 2,139 2,139 5 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.